These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24134780)

  • 1. Public health aspects of snakebite care in West Africa: perspectives from Nigeria.
    Habib AG
    J Venom Anim Toxins Incl Trop Dis; 2013 Oct; 19(1):27. PubMed ID: 24134780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
    Habib AG; Warrell DA
    Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.
    Abubakar IS; Abubakar SB; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Theakston RD; Juszczak E; Alder N; Warrell DA;
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e767. PubMed ID: 20668549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
    Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
    Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria.
    Abubakar SB; Abubakar IS; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Laing GD; Theakston RD; Juszczak E; Alder N; Warrell DA;
    Toxicon; 2010 Apr; 55(4):719-23. PubMed ID: 19874841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
    Sánchez A; Segura Á; Vargas M; Herrera M; Villalta M; Estrada R; Wu F; Litschka-Koen T; Perry MA; Alape-Girón A; León G
    Toxicon; 2017 Jan; 125():59-64. PubMed ID: 27890775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
    Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
    Calvete JJ; Cid P; Sanz L; Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Theakston RD; Warrell DA; Gutiérrez JM
    Am J Trop Med Hyg; 2010 Jun; 82(6):1194-201. PubMed ID: 20519622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snake bite in Nigeria.
    Habib AG; Gebi UI; Onyemelukwe GC
    Afr J Med Med Sci; 2001 Sep; 30(3):171-8. PubMed ID: 14510123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria.
    Sánchez LV; Pla D; Herrera M; Chippaux JP; Calvete JJ; Gutiérrez JM
    Toxicon; 2015 Nov; 106():97-107. PubMed ID: 26415904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
    Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational phase IV study on effectiveness of animal derived polyclonal antibody antivenoms against West African carpet viper (Echis romani) induced coagulopathy and mortality.
    Dajel TB; Abubakar SB; Dan-Amarya NM; Azi NA; Mu'azu S; Hamza M; Iliyasu G; Gwarzo MY; Habib AG
    Toxicon; 2023 Aug; 232():107211. PubMed ID: 37393958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Pasteur and Behringwerke antivenoms in envenoming by the carpet viper (Echis carinatus).
    Warrell DA; Warrell MJ; Edgar W; Prentice CR; Mathison J; Mathison J
    Br Med J; 1980 Mar; 280(6214):607-9. PubMed ID: 7370603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom proteomic analysis of medically important Nigerian viper
    Dingwoke EJ; Adamude FA; Mohamed G; Klein A; Salihu A; Abubakar MS; Sallau AB
    Biochem Biophys Rep; 2021 Dec; 28():101164. PubMed ID: 34765747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
    Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
    Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes among snakebite patients in north-west Ethiopia-A retrospective analysis.
    Steegemans I; Sisay K; Nshimiyimana E; Gebrewold G; Piening T; Menberu Tessema E; Sahelie B; Alcoba G; Gebretsadik FS; Essink D; Collin S; Lucero E; Ritmeijer K
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010148. PubMed ID: 35139079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.